RxDoctor Payments Data

Stephen Sherwin

Medical Oncology · San Francisco, CANPI 1437461431

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,752,097 of the $6,879,066 with a category attached, or 98.2%. 5 manufacturers reported payments, led by Neurocrine Biosciences, Inc. at 49.1% of the total. Among medical oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,879,066in general payments, 2019–2025

Across 336 payments — averaging $20,473 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$3.4M
  • Biogen$2.7M
  • Exelixis Inc.$718K
  • AbbVie$33K
  • Verastem, Inc.$14K

What the payments were for

  • Consulting fees$6,752,09798%
  • Travel & lodging$85,1741%
  • Food & beverage$8,7570%
  • Other$33,0380%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Neurocrine Biosciences, Inc.234$3,379,695
Biogen64$2,735,214
Exelixis Inc.29$717,505
AbbVie3$33,038
Verastem, Inc.6$13,614

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,879,066 in reported general payments places this provider in the 95th percentile of 379 medical oncology providers in California.

See all medical oncology providers in California

Other medical oncology in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →